SCHEMBL5208094

SCHEMBL5208094

CC(C)n1nc(CNC(=O)O)c(Cc2ccncc2)c1Sc1cc(Cl)cc(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.36
ATM Q13315 1/20 0.34
LMNA P02545 3/20 0.34
HTT P42858 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
GAA P10253 2/20 0.33
KLKB1 P03952 1/20 0.33
NAMPT P43490 1/20 0.33
FLT1 P17948 3/20 0.32
KDR P35968 3/20 0.32
CYP3A4 P08684 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
P2RX3 P56373 1/20 0.32
CSF1R P07333 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5210884 0.92 ATM (0.34) POLBATMLMNAHTTALDH1A1
SCHEMBL5211288 0.85 FLT1 (0.35) ALDH1A1FLT1KDR
SCHEMBL5209929 0.85 FLT1 (0.32) FLT1KDR
SCHEMBL5212152 0.84 SLC16A3 (0.32) FLT1KDR
Hydrochloric Acid SCHEMBL5207976 0.83 FLT1 (0.35) FLT1KDR
SCHEMBL5208158 0.83 FLT1 (0.35) FLT1KDR
SCHEMBL5211498 0.83 FLT1 (0.32) LMNAHTTALDH1A1KDM4EL3MBTL1
SCHEMBL5244657 0.82 FLT1 (0.37) POLBALDH1A1FLT1KDRCYP1A2
SCHEMBL14564994 0.82 FLT1 (0.33) FLT1KDR
SCHEMBL5208166 0.80 FLT1 (0.34) FLT1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401826-B1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2007-03-21 EP claimed
EP-1401826-B1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS HOFFMANN LA ROCHE (CH) 2007-03-21 EP disclosed
EP-1401826-A1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2004-03-31 EP disclosed
US-6538015-B1 Process for their manufacture, pharmaceutical compositions and the use of such compounds in medicine. In particular, the compounds of formula I are inhibitors of the human immunodeficiency virus reverse transcriptase enzyme which is HOFFMANN-LA ROCHE INC. 2003-03-25 US disclosed
WO-2002100853-A1 PYRAZOLE DERIVATIVES AS HIV REVERSE TRANSCRIPTASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-12-19 WO disclosed